Medications called incretin-based therapies, used for type 2 diabetes, are associated with better heart health due to their effects on reducing inflammation, lowering blood pressure, and helping with...

Pro

Against

Evidence from Studies

Supporting (3)

Community contributions welcome

Effect of Incretin-Based Therapies on Blood Pressure: A Systematic Review and Meta-Analysis.

Systematic Review With Meta-Analysis

Human

2026 May 15

Untitled Study

Contradicting (0)

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Similar Assertions

Medications that target incretin hormones lower the risk of illness and death in people with diabetes by improving how the body processes glucose and functions of the heart and blood vessels.

87%

Adults with overweight or obesity who take incretin-based therapies have a lower risk of dying from any cause compared to those who do not, based on combined data from multiple studies.

75%

In adults with overweight or obesity who are taking incretin-based therapies, those who lose more weight tend to have larger decreases in both their systolic and diastolic blood pressure.

71%